Polymorph screening and solubility characterisation of lercanidipine HCL (2018)
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: ANTAGONISTAS, SOLUBILIDADE
ABNT
REPIN, Ilia Alekseevich et al. Polymorph screening and solubility characterisation of lercanidipine HCL. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 set. 2024. , 2018APA
Repin, I. A., Ferraz, H. G., Antonio, S. G., & Araujo, G. L. B. de. (2018). Polymorph screening and solubility characterisation of lercanidipine HCL. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Repin IA, Ferraz HG, Antonio SG, Araujo GLB de. Polymorph screening and solubility characterisation of lercanidipine HCL. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 15 res. FCF025.[citado 2024 set. 16 ]Vancouver
Repin IA, Ferraz HG, Antonio SG, Araujo GLB de. Polymorph screening and solubility characterisation of lercanidipine HCL. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 15 res. FCF025.[citado 2024 set. 16 ]